Breaking News

Audax Private Equity Invests in Pyramid Laboratories

Investment supports growth of the company’s clinical and commercial biologics and advanced therapeutics manufacturing and service operations.

Audax Private Equity, an alternative investment manager and capital partner, has made a growth investment in Pyramid Laboratories, Inc., to support the continued growth of the company’s clinical and commercial biologics and advanced therapeutics manufacturing and service operations.  Pyramid is a drug product contract development and manufacturing organization (CDMO). The company provides formulation development, analytical and stability testing, as well as aseptic fill-finish manufacturing s...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters